ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,649Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 2061

$1.36M Total Retail Price of All Prescriptions

Rank: 41 out of 2061

819 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 819 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 819 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 21,646 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 1,005 856 1 1
LEVOTHYROXINE SODIUM 892 784 2 3
OMEPRAZOLE 839 621 3 5
AMLODIPINE BESYLATE 767 690 4 4
FUROSEMIDE 760 677 5 6
METOPROLOL TARTRATE 607 509 6 7
LISINOPRIL 548 452 7 2
DONEPEZIL HCL 477 437 8 24
CITALOPRAM HBR 456 388 9 20
TRAMADOL HCL 420 336 10 18
HYDROCODONE-ACETAMINOPHEN 414 388 S3 11 10
TRAZODONE HCL 385 283 12 39
NAMENDA 373 341 13 37
POTASSIUM CHLORIDE 369 333 14 16
MELOXICAM 348 283 15 44
WARFARIN SODIUM 346 326 16 11
MIRTAZAPINE 312 284 17 46
HYDROCHLOROTHIAZIDE 308 252 18 12
ATORVASTATIN CALCIUM 297 209 19 8
GABAPENTIN 270 202 20 15
SERTRALINE HCL 256 154 21 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 255 220 22 27
CIPROFLOXACIN HCL 254 237 23 54
POLYETHYLENE GLYCOL 3350 254 212 23 64
OXYCODONE HCL 251 182 S2 25 82
ATENOLOL 248 237 26 13
METFORMIN HCL 222 170 27 9
METOPROLOL SUCCINATE 204 204 28 19
CLOPIDOGREL 197 172 29 29
RISPERIDONE 196 150 30 66
PREDNISONE 196 159 30 32
VITAMIN D2 192 192 32 146
OXYCODONE-ACETAMINOPHEN 187 172 S2 33 36
HALOPERIDOL 182 151 34 153
ALENDRONATE SODIUM 178 161 35 25
TAMSULOSIN HCL 176 141 36 30
QUETIAPINE FUMARATE 172 99 37 72
FLUTICASONE PROPIONATE 170 115 38 43
PRAVASTATIN SODIUM 167 123 39 14
AZITHROMYCIN 167 141 39 34
FENTANYL 167 139 S2 39 84
ZOLPIDEM TARTRATE 158 107 42 23
CYMBALTA 155 110 43 59
DIVALPROEX SODIUM 153 113 44 74
ADVAIR DISKUS 152 98 45 57
PLAVIX 149 127 46 49
CARVEDILOL 149 120 46 22
EXELON 148 142 48 94
ISOSORBIDE MONONITRATE ER 146 133 49 42
LANTUS 145 125 50 48
ALLOPURINOL 145 98 50 28
CARBIDOPA-LEVODOPA 141 134 52 97
NYSTATIN 139 112 53 148
VENLAFAXINE HCL 129 118 54 193
LYRICA 129 125 54 83
DOXYCYCLINE HYCLATE 118 101 56 98
FLUOXETINE HCL 118 40 56 73
CRESTOR 116 65 58 31
LEVOFLOXACIN 116 102 58 111
ESCITALOPRAM OXALATE 115 107 60 77
VENLAFAXINE HCL ER 115 65 60 109
CEPHALEXIN 112 74 62 112
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 103 63 87
LOSARTAN POTASSIUM 108 104 64 17
PAROXETINE HCL 108 95 64 61
SPIRIVA 106 53 66 63
IPRATROPIUM BROMIDE 105 86 67 167
PROMETHAZINE HCL 100 68 R 68 119
LACTULOSE 99 96 69 131
CEFUROXIME 99 84 69 170
FINASTERIDE 96 83 71 86
LEXAPRO 94 86 72 211
TRIAMCINOLONE ACETONIDE 93 77 73 172
ALBUTEROL SULFATE 91 83 74 104
LOSARTAN-HYDROCHLOROTHIAZIDE 91 75 74 50
ROPINIROLE HCL 90 44 76 92
CILOSTAZOL 89 72 77 189
FENOFIBRATE 87 87 78 65
BACLOFEN 87 15 78 123
LOVASTATIN 86 73 80 35
RANITIDINE HCL 86 65 80 53
LEVETIRACETAM 86 56 80 102
AMOX TR-POTASSIUM CLAVULANATE 85 71 83 113
LANTUS SOLOSTAR 85 43 83 76
NOVOLOG 85 75 83 102
PANTOPRAZOLE SODIUM 83 66 86 45
KLOR-CON M20 81 53 87 47
METOCLOPRAMIDE HCL 78 28 88 138
BENZTROPINE MESYLATE 78 25 R 88 149
METHYLPREDNISOLONE 77 73 90 101
OXYBUTYNIN CHLORIDE ER 76 69 91 80
NYSTOP 75 64 92 185
HEPARIN SODIUM 75 71 92 273
ABILIFY 75 47 92 160
SEROQUEL 73 48 95 157
KLOR-CON 10 73 70 95 141
ZETIA 72 72 97 68
DIPHENOXYLATE-ATROPINE 72 52 97 324
SPIRONOLACTONE 70 53 99 62
NEXIUM 69 44 100 26
PHENYTOIN SODIUM EXTENDED 64 37 101 145
PREMARIN 63 36 R 102 251
OLANZAPINE 63 30 102 132
LITHIUM CARBONATE 61 24 104 313
ESTRADIOL 61 41 R 104 266
PROPRANOLOL HCL 58 13 106 143
HYDRALAZINE HCL 57 45 107 69
DIVALPROEX SODIUM ER 56 28 108 188
FELODIPINE ER 55 55 109 246
LIDODERM 54 52 110 106
GEMFIBROZIL 54 38 110 107
AGGRENOX 53 53 112 279
MORPHINE SULFATE 53 50 S2 112 319
CARAFATE 52 51 114 310
GLIPIZIDE 52 43 114 55
MORPHINE SULFATE ER 51 47 S2 116 166
NOVOLOG FLEXPEN 51 29 116 177
LIPITOR 50 35 118 70
DIGOXIN 50 47 118 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.